Fund Manager Summary on Healthco Healthcare and Wellness Reit (ASX:HCW)
In December 2025, Blackwattle Investment Partners commented that Healthco Healthcare and Wellness Reit (ASX:HCW) continues to face tenant uncertainty as Healthscope remains in receivership and the market awaits completion of the receiver‑led sales process, with the expectation that announcements of new tenants could be a near‑term catalyst. Across fund manager commentary, a consensus has emerged that HCW’s portfolio — concentrated in 11 hospitals leased to Healthscope — benefits from structural demand for essential healthcare real estate but is materially de‑rated by tenant distress: Oracle Advisory Group took a full sell stance in March 2025 after Healthscope’s rising costs, an over‑leveraged capital structure (around $1.6bn of debt) and a missed rental payment, while Blackwattle’s June, November and December 2025 reports have viewed the receivership and potential recapitalisation or sale as a reset that could allow cost reduction, single‑digit rent concessions paired with lease extensions, and eventual closure of a >50% discount to NTA, creating upside (including a forecasted yield >12% on dividend resumption). Key risks are tenant viability, ongoing rent payment disruption, a protracted sale/receivership process and portfolio concentration; opportunities include replacement by not‑for‑profit or lower‑cost operators, potential government support for private hospital funding and NTA re‑rating when tenant uncertainty resolves. Actionable considerations for investors are to closely monitor receiver process milestones and sale announcements, the status of rental payments or formal rent amendments, any confirmed lease extensions or new tenant agreements, NTA movements and dividend guidance to time repositioning or risk reduction.
Commentary From The Managers
There are 4 insights from 2 fund managers regarding their investment in Healthco Healthcare and Wellness Reit (ASX:HCW) available on Thesis Tracker.
Unlock Updates With ThesisTracker Pro
Don’t let information asymmetry undermine your investment returns. Join other engaged investors on ThesisTracker Pro.
Updates are made available to members within 12 hours of being released. The completeness, accuracy or current status of the investments referenced are not guaranteed.
Commentary From The Managers
Blackwattle Investment Partners
31 Dec 2025
$0.73
Summary
- Blackwattle Investment Partners believes HealthCo REIT offers an attractive risk/reward and initiated a position because the stock has traded to a ~50% discount to NTA amid receivership-driven uncertainty, providing a significant margin of safety.
- Major landlord to Healthscope: HCW is a key landlord to Healthscope, one of Australia’s largest private hospital operators.
- Receivership pressure: Healthscope has been in receivership for most of 2025 after its private equity owners became over-geared, creating uncertainty over tenant viability and future ownership.
- Share price impact: That uncertainty has driven HCW’s share price materially lower, including a notable decline in December as the market awaited the receiver-led sales process.
- Active buyer interest: A significant number of parties are seeking to purchase the operating business, especially not-for-profit operators with a structural cost advantage.
- Policy tailwind: The Federal Government is looking to improve private hospital funding as an essential service, which could support longer-term stability for tenants.
- Near-term catalyst: We expect HCW to be in a position to announce new tenants in coming weeks once the receiver completes sales, which would be a key catalyst for re‑rating.
- Investment rationale: Deep NTA discount, active buyer interest, and potential policy support underpin our conviction to hold a position.
Blackwattle Investment Partners
30 Nov 2025
$0.83
Summary
- Blackwattle Investment Partners updates their investment thesis on HealthCo REIT (HCW)
- HCW is a major landlord to Healthscope — HealthCo REIT was the landlord to one of Australia’s largest private hospital operators and its share price has recently rallied +20.6%.
- Healthscope in receivership through most of 2025, creating significant uncertainty over tenant sustainability and future ownership.
- HCW traded up to a 50% discount to NTA despite multiple parties interested in buying the operating business and the network providing an essential community service.
- Press-driven stakeholder agendas increased market uncertainty, which Blackwattle viewed as creating an opportunity to acquire exposure to HCW at a deep discount.
- Receiver-led sales process nearing completion — final bids received and press reports of other landlords entering binding agreements to install new tenants, supporting a reduction in downside risk.
- Share price rallied in November as the sales process progressed and market confidence improved.
- Blackwattle sees meaningful upside when the Healthscope portfolio is sold, since a completed sale would materially reduce rent income uncertainty and should narrow the valuation gap.
- Blackwattle Investment Partners continues to hold because the investment case is driven by exposure to a deep discount to NTA, visible buyer interest in the operating business, and the prospect of rent clarity following a sale.
- These points reflect Blackwattle Investment Partners’ views and are not financial advice.
Blackwattle Investment Partners
30 June 2025
$0.74
Summary
- HealthCo REIT has seen a decline of 17.4% but remains a landlord of high-quality healthcare properties, including 11 hospitals leased to Healthscope.
- Healthcare properties benefit from consistent demand as they provide essential services to the community.
- Current valuation is trading at a 50% discount to its asset backing (NTA) due to Healthscope's restructuring process.
- The restructuring includes a recapitalisation and sale process that has caused concern among some investors.
- Blackwattle Investment Partners views the administration process as a catalyst for Healthscope to reduce its cost base, which is essential for paying rent and retaining leases.
- Expected rental discounts from HealthCo management are likely to be single-digit changes, paired with lease term extensions.
- Restructuring is anticipated to conclude in the coming months, leading to a potential closure of the NTA discount.
- Upon resumption of full dividends, a forecasted yield greater than 12% per annum is expected at the current share price.
Oracle Advisory Group
31 Mar 2025
$0.89
Summary
- Oracle Advisory Group sold their investment due to uncertainty around their key tenant, Healthscope.
- Healthscope is facing difficulties from increased costs.
- The company has an over-leveraged capital structure, with $1.6bn in debt.
- The decision to sell was further justified when HealthCo Reit announced that Healthscope had failed to make rental payments in March.
The completeness, accuracy or current status of the investments referenced are not guaranteed.
Frequently Asked Questions
Who is investing in Healthco Healthcare and Wellness Reit (ASX:HCW)?
Fund managers including Oracle Advisory Group and Blackwattle Investment Partners have invested in Healthco Healthcare and Wellness Reit (ASX:HCW).
Why do fund managers invest in Healthco Healthcare and Wellness Reit?
Fund managers are drawn to Healthco Healthcare and Wellness REIT due to its portfolio of essential healthcare properties, which demonstrate consistent demand. Despite current challenges related to its primary tenant, Healthscope's financial restructuring, investors see potential for recovery as this process may stabilize rental payments and enhance asset valuations. The REIT trades at a substantial discount to its net tangible asset backing, presenting a potential value opportunity, and may offer an attractive yield of over 12% upon resuming full dividends.
What happened to Healthco Healthcare and Wellness Reit (ASX:HCW)?
Fund managers are investing in Healthco Healthcare and Wellness REIT due to its strategic position as a major landlord for Healthscope, Australia’s leading private hospital operator. Despite facing uncertainties related to Healthscope's receivership, the REIT currently trades at a significant discount to its Net Tangible Assets (NTA). Several interested buyers for Healthscope's operating business suggest potential for recovery and value appreciation. As the receivership process draws to a close, the anticipated resolution of rental income uncertainties is expected to drive the share price higher.
What is the short interest in Healthco Healthcare and Wellness Reit (ASX:HCW)?
The short interest in Healthco Healthcare and Wellness Reit (ASX:HCW) is 0.72% which makes it the 240th most shorted stock on the ASX. Of the 550.2M shares that Healthco Healthcare and Wellness Reit has on issue, 3.9M have been sold short.
What does Healthco Healthcare and Wellness Reit (ASX:HCW) do?
HealthCo Healthcare & Wellness REIT is a managed investment scheme company. It invests in various portfolios including hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness property assets, as well as other healthcare and property adjacencies. The company was founded in the year 2021 and is headquartered in Sydney, Australia.